Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
5.82
+0.23 (4.11%)
At close: Oct 8, 2025, 4:00 PM EDT
5.93
+0.11 (1.87%)
After-hours: Oct 8, 2025, 7:59 PM EDT
Neogen Revenue
In the fiscal year ending May 31, 2025, Neogen had annual revenue of $894.66M, down -3.20%. Neogen had revenue of $225.46M in the quarter ending May 31, 2025, a decrease of -4.79%.
Revenue (ttm)
$894.66M
Revenue Growth
-3.20%
P/S Ratio
1.41
Revenue / Employee
$300,828
Employees
2,974
Market Cap
1.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2025 | 894.66M | -29.56M | -3.20% |
May 31, 2024 | 924.22M | 101.78M | 12.37% |
May 31, 2023 | 822.45M | 295.29M | 56.01% |
May 31, 2022 | 527.16M | 58.70M | 12.53% |
May 31, 2021 | 468.46M | 50.29M | 12.03% |
May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NEOG News
- 1 day ago - Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings - Benzinga
- 13 days ago - Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education - Business Wire
- 20 days ago - Neogen Announces First-Quarter Earnings Release Date - Business Wire
- 23 days ago - Neogen® Announces CFO Transition Plan - Business Wire
- 4 weeks ago - Neogen: A Nibble With The Sale Of An Out-Of-The-Money Call That Can Be Rolled Forward - Seeking Alpha
- 4 weeks ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 16, 2025 in Neogen Corporation Lawsuit – NEOG - GlobeNewsWire
- 7 weeks ago - The Bottom Fishing Club - Neogen: Combine Business Turnaround With Defensive Trading History - Seeking Alpha
- 7 weeks ago - Neogen Announces Board Transition with Appointment of Avi Pelossof and the Retirement of William Boehm - Business Wire